This review describes how patient-derived stem cells contribute to understanding the disease mechanism at the cellular level and use this for discovery of potential new therapeutics, focusing on SPAST mutations, the most common cause of HSP. The gene discussed is SPAST; the disease is hereditary spastic paraplegia.